These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29580573)

  • 1. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
    Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C
    Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pitfalls and typical false interpretations in bone tumors. From the viewpoint of long-term consultation].
    Salzer-Kuntschik M
    Pathologe; 1996 Jan; 17(1):1-5. PubMed ID: 8685089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chondroblastoma occurring in atypical sites].
    Jiang ZM; Zhang HZ; Tan YS; Tang RY; Liu HM; Lu SH; Shu MJ; Zeng BF; Yang SX; Chen JQ; Huang J
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):503-7. PubMed ID: 15634443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
    Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
    J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumors affecting the temporomandibular joint - a literature review].
    Schlund M; Roland-Billecart T; Aubert S; Nicot R
    Bull Cancer; 2020 Nov; 107(11):1186-1198. PubMed ID: 33059872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration diagnosis of aggressive giant cell tumor of bone. A case report.
    Ríos-Martín J; Otal-Salaverri C; Vázquez-Ramírez FJ; González-Cámpora R; Davidson HG
    Acta Cytol; 1995; 39(3):550-4. PubMed ID: 7762351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Giant cell-containing tumors of bone and differential diagnoses].
    Heitkötter B; Hartmann W
    Pathologe; 2022 May; 43(3):174-182. PubMed ID: 35467097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience.
    Hammas N; Laila C; Youssef AL; Hind el F; Harmouch T; Siham T; Afaf A
    Diagn Pathol; 2012 Sep; 7():130. PubMed ID: 23016917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditions that mimic osteosarcoma.
    Raymond AK; Jaffe N
    Cancer Treat Res; 2009; 152():85-121. PubMed ID: 20213387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue and bone tumors about the foot and ankle.
    Walling AK; Gasser SI
    Clin Sports Med; 1994 Oct; 13(4):909-38. PubMed ID: 7805113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 expression in giant cell-containing lesions of bone and soft tissue.
    de la Roza G
    Arch Pathol Lab Med; 2011 Jun; 135(6):776-9. PubMed ID: 21631272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis of giant cell-rich lesions of bone].
    Lang S
    Pathologe; 2008 Nov; 29 Suppl 2():245-9. PubMed ID: 18836722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components.
    Çomunoğlu N; Kepil N; Dervişoğlu S
    Acta Orthop Traumatol Turc; 2019 Jan; 53(1):35-39. PubMed ID: 30392920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions.
    Hui M; Uppin SG; Kumar KK; Radhika S; Chandrasekhar P; Rao KN
    Turk Patoloji Derg; 2022; 38(1):9-15. PubMed ID: 34514571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Giant-cell tumor of bone in 2022].
    Larousserie F; Audard V; Burns R; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.